[ET Net News Agency, 5 September 2025] KEYMED BIO-B (02162) rose 10.1% to HK$75.4.
It hits an intra-day high of HK$75.4, breaking above the 20-D SMA of HK$71.33, and an
intra-day low of HK$68.5. The total shares traded was 2.36 million, with a value of
HK$171.27m. The active buy/sell ratio is 69:31, with net buying turnover of HK$63.33m.
J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$6.31m,
with volume weighted average price of HK$72.063. CHINA INV INFO accounts for greatest net
responsive selling turnover of HK$30.96m, with volume weighted average price of HK$73.485.

Basic Information
=================

----------------------------------
Nominal 75.400 % Chg +10.07%
High 75.400 Low 68.500
Shares Tr 2.36m Turnover 171.27m
10-D SMA 70.620 %H.V 58.592
20-D SMA 71.330 VWAP 72.542
50-D SMA 61.845 RSI14 61.948
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 69:31, with net buying
turnover of HK$63.33m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 75.40 +10.07
SINO BIOPHARM (01177) 8.83 +5.24
3SBIO (01530) 32.92 +9.15
EVEREST MED (01952) 60.65 +2.54
WUXI XDC (02268) 64.65 +2.38
ASCENTAGE-B (06855) 78.00 +3.93
ZAI LAB (09688) 24.04 +4.34
AKESO (09926) 153.10 +4.01
INNOCARE (09969) 17.65 +1.26
REMEGEN (09995) 91.00 +0.61
---------------------------------------------
(ed)